Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist

BACKGROUND: Cystic fibrosis (CF) is a genetic disease that may result in multiple systemic disorders and potentially fatal severe respiratory compromise. However, the advent of CF transmembrane conductance regulator (CFTR) modulators has changed the management of CF for patients with select mutation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Saangyoung E., Farzal, Zainab, Daniels, M.Leigh Anne, Thorp, Brian D., Zanation, Adam M., Senior, Brent A., Ebert, Charles S., Kimple, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573678/
https://www.ncbi.nlm.nih.gov/pubmed/32168995
http://dx.doi.org/10.1177/1945892420912368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573678/
https://www.ncbi.nlm.nih.gov/pubmed/32168995
http://dx.doi.org/10.1177/1945892420912368

Ejemplares similares